SEARCH

SEARCH BY CITATION

References

  • 1
    Talley NJ, Colin-Jones D, Koch KL, et al. Functional dyspepsia: A classification with guidelines for diagnosis and management. Gastroenterol Int 1991; 4: 145 60.
  • 2
    Jebbink HJA, Smout AJPM, Van Berge-Henegouwen GP. Pathophysiology and treatment of functional dyspepsia. Scand J Gastroenterol 1993; 28(Suppl. 200): 8 14.
  • 3
    Jones R & Lydeard S. Prevalence of symptoms of dyspepsia in the community. Lancet 1989; 1: 47 51.
  • 4
    Jones RH, Lydeard SE, Hobbs FDR, et al. Dyspepsia in England and Scotland. Gut 1990; 31: 401 5.
  • 5
    Gear MWL & Barnes RJ. Endoscopic studies of dyspepsia in a general practice. Br Med J 1989; 1: 1136 7.
  • 6
    Jones R. Upper gastrointestinal endoscopy—a view from general practice. J R Coll Gen Pract 1986; 36: 6 8.
  • 7
    Williams B, Luckas M, Ellingham JHM, et al. Do young patients with dyspepsia need investigation? Lancet 1988; 11: 1349 51.
  • 8
    Forrester E. Alternative advice on dyspepsia treatment. Gastroenterol Pract 1994; Feb/Mar: 6 7.
  • 9
    Heatley R. Dyspepsia: GP guide to drug management. Prescriber 1995; 19 October: 39 50.
  • 10
    Crompton B. Dyspepsia: A rational approach to management. Prescriber 1995; 19 October: 52 56.
  • 11
    Bytzer P, Hansen JM, Schaffalitzky de Muckadell OB. Empirical H2-blocker therapy or prompt endoscopy in management of dyspepsia . Lancet 1994; 343: 811 16.
  • 12
    Thompson G. Dyspepsia: Is a trial of therapy appropriate?. Can Med Assoc J 1995; 153: 293 329.
  • 13
    Dundee Dyspepsia Management Guidelines, 1996.
  • 14
    Mucklow JC, Haycox AR, Wood KMG, Jones PW, Green JRB. Cost-effective management of dyspepsia. Br J Med Econ 1996; 10: 119 27.
  • 15
    British Society of Gastroenterology. Guidelines in Gastroenterology 1: Dyspepsia Management Guidelines, British Society of Gastroenterology, September 1996.
  • 16
    Lobo A & Dickinson R. Managing the dyspeptic patient: Experience of a single visit dyspepsia clinic. J R Soc Med 1988; 81: 212 13.
  • 17
    Bramble MG, Cooke WM, Corbett WA, et al. Organising unrestricted open access gastroscopy in South Tees. Gut 1993; 34: 422 7.
  • 18
    Porro GB, Pace F, Sangaletti O, et al. Double-blind clinical study of an alginate compound vs. ranitidine in patients with gastroesophageal reflux disease. Adv Ther 1992; 9: 166 73.
  • 19
    Holt S & Howden C. Omeprazole: Overview and opinion. Dig Dis Sci 1991; 36: 385 93.
  • 20
    Laursen LS, Bondesen S, Hansen J, et al. Omeprazole 10 mg or 20 mg daily for the prevention of relapse in gastroesophageal reflux disease? A double-blind comparative study. Gastroenterology 1992; 102(Suppl. 4, pt 2): A109(Abstract).
  • 21
    Yeomans ND, Prichard PJ, Jones DB, et al. Morning or evening dosing with low-dose omeprazole: Effects on 24-hour gastric acidity profiles in duodenal ulcer patients. Scand J Gastroenterol 1986; 21(Suppl. 118): 152 3.
  • 22
    Robinson M, Maton PN, Allen ML, et al. Effect of different doses of omeprazole on 24-hour oesophageal acid exposure in patients with gastro-oesophageal reflux. Aliment Pharmacol Ther 1991; 5: 645 61.
  • 23
    Depuy HJ. The Psychological General Well-Being (PGWB) Index. In: Wenger NK, Mattson ME, Furberg CD, Elinsson J, eds. Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. Le Jacq Publishing Inc. USA, 1984: 170 183.
  • 24
    Dimenas E, Glise H, Hallerback B, et al. Quality of life in patients with upper gastrointestinal symptoms. An improved evaluation of treatment regimens? Scand J Gastroenterol 1993; 28: 681 7.
  • 25
    Glise H. Measurement of the impact of heartburn and dyspepsia on Quality of Life. In: Proceedings Heartburn & Dyspepsia—Diagnostic Challenge, Healthcare Dilemma. Barcelona, Spain, 25th November 1995: 32 34.
  • 26
    Manning AP, Thompson WG, Heaton KW, et al. Towards positive diagnosis of the irritable bowel. Br Med J 1978; 2: 653 4.
  • 27
    Green JRB. Is there such an entity as mild oesophagitis? Eur J Clin Res 1993; 4: 29 34.
  • 28
    Labenz J, Tillenburg B, Peitz U, et al. Helicobacterpylori augments the pH-increasing effect of omeprazole in patients with duodenal ulcer. Gastroenterology 1996; 110(3): 725 32.
  • 29
    Sharp J, Logan RPH, Walker MM, et al. Effect of omeprazole in Helicobacter pylori. Gut 1991; 32: A565(Abstract).
  • 30
    Weil J, Bell GD, Powell K, et al. Omeprazole and Helicobacter pylori: temporary suppression rather than true eradication . Aliment Pharmacol Ther 1991; 5: 309 13.